Sandbox: wdx causes: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 145: | Line 145: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 169: | Line 169: | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Aplastic anemia | ! align="center" style="background:#DCDCDC;" |Aplastic anemia | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | * Immune destruction | ||
| align="center" style="background:#F5F5F5;" + | | |||
| align="center" style="background:#F5F5F5;" + | + | |||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 199: | Line 200: | ||
| align="center" style="background:#F5F5F5;" + |Immune destruction | | align="center" style="background:#F5F5F5;" + |Immune destruction | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 285: | Line 286: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 307: | Line 308: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |||
!Category | |||
!Condition | |||
!Etiology | |||
!Bone marrow infiltration | |||
!Bone marrow failure | |||
!Destruction/ | |||
sequestration/ | |||
redistribution | |||
!Congenital | |||
!Acquried | |||
!Demography | |||
!History | |||
!Appearance | |||
!Fever | |||
!Bleeding | |||
!BP | |||
!Splenomegaly | |||
!Jaundice | |||
!Other signs | |||
!Plt | |||
!HB | |||
!WBC | |||
!PBS | |||
!Bone marrow exam | |||
!PT | |||
!PTT | |||
!UA | |||
!Imaging | |||
!Gold standard | |||
!Associated findings | |||
|- | |- | ||
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunology/ | ! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunology/ | ||
Line 371: | Line 403: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 399: | Line 431: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 427: | Line 459: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 484: | Line 516: | ||
* Splenomegaly | * Splenomegaly | ||
* Bone marrow infiltration | * Bone marrow infiltration | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 509: | Line 541: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |||
!Category | |||
!Condition | |||
!Etiology | |||
!Bone marrow infiltration | |||
!Bone marrow failure | |||
!Destruction/ | |||
sequestration/ | |||
redistribution | |||
!Congenital | |||
!Acquried | |||
!Demography | |||
!History | |||
!Appearance | |||
!Fever | |||
!Bleeding | |||
!BP | |||
!Splenomegaly | |||
!Jaundice | |||
!Other signs | |||
!Plt | |||
!HB | |||
!WBC | |||
!PBS | |||
!Bone marrow exam | |||
!PT | |||
!PTT | |||
!UA | |||
!Imaging | |||
!Gold standard | |||
!Associated findings | |||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infections | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infections | ||
Line 545: | Line 608: | ||
* Splenomegaly | * Splenomegaly | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 575: | Line 638: | ||
* Ineffective hematopoiesis | * Ineffective hematopoiesis | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 694: | Line 757: | ||
* Immune destruction | * Immune destruction | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + |+ | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 722: | Line 785: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Condition | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow infiltration | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bone marrow failure | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Destruction/ | ||
sequestration/ | |||
redistribution | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquried |
Revision as of 20:54, 4 September 2018
Differentiating Pancytopenia from Other Diseases
- Pancytopenia must be differentiated from a pseudo-syndromes like pseudo-thrombocytopenia, which is a laboratory artifact from platelet clumping.
- There are no other mimickers of pancytopenia, as the diagnosis can be unequivocally established by laboratory testing (complete blood count).
Category | Condition | Etiology | Mechanism | Congenital | Acquried | Clinical manifestations | Para−clinical findings | Gold standard | Associated findings | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | ||||||||||||||||||||||||
Lab Findings | Imaging | ||||||||||||||||||||||||||
Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other | CBC | PBS | Bone marrow exam | PT | PTT | UA | |||||||||||||||
Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Plt | HB | WBC | ||||||||||||||||||||||
Hematologic disorders | Myelodysplastic syndromes (MDS) |
|
|||||||||||||||||||||||||
Malignancies such as:
|
|
+ | + | + | |||||||||||||||||||||||
Myelofibrosis |
|
+ | |||||||||||||||||||||||||
Fanconi anemia | + | ||||||||||||||||||||||||||
Aplastic anemia |
|
+ | |||||||||||||||||||||||||
Paroxysmal nocturnal hemoglobinuria | Immune destruction | + | |||||||||||||||||||||||||
Disseminated intravascular coagulation | Consumption | ||||||||||||||||||||||||||
Dyskeratosis congenital/telomere biology disorders | |||||||||||||||||||||||||||
Shwachman-Diamond syndrome | + | ||||||||||||||||||||||||||
Category | Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings |
Immunology/
Rheumatology |
SLE | ||||||||||||||||||||||||||
Felty syndrome | |||||||||||||||||||||||||||
Wiskott Aldrich syndrome | + | ||||||||||||||||||||||||||
GATA2 deficiency | + | ||||||||||||||||||||||||||
Hemophagocytic lymphohistiocytosis (HLH) | + | ||||||||||||||||||||||||||
GI disorders | Portal hypertension/cirrhosis |
|
|||||||||||||||||||||||||
Storage diseases (eg, Gaucher) |
|
+ | + | ||||||||||||||||||||||||
Category | Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings |
Infections | Sepsis |
|
|||||||||||||||||||||||||
Viral infection such as HIV, hepatitis, Epstein-Barr virus |
|
+ | + | ||||||||||||||||||||||||
Nutritional | Megaloblastic anemia |
|
+ | ||||||||||||||||||||||||
Excessive alcohol |
|
||||||||||||||||||||||||||
Other (eg, copper deficiency, zinc toxicity) |
|
||||||||||||||||||||||||||
Malnutrition |
|
||||||||||||||||||||||||||
Medications | Medications such as:
|
|
+ | ||||||||||||||||||||||||
Category | Condition | Etiology | Bone marrow infiltration | Bone marrow failure | Destruction/
sequestration/ redistribution |
Congenital | Acquried | Demography | History | Appearance | Fever | Bleeding | BP | Splenomegaly | Jaundice | Other signs | Plt | HB | WBC | PBS | Bone marrow exam | PT | PTT | UA | Imaging | Gold standard | Associated findings |